Altered levels of DAT expression alongside DA irregularities are found in neuropsychiatric disorders in which also cognition is known to be affected, including attention-deficit hyperactive disorder (ADHD) and schizophrenia but also Tourette syndrome (TS) [11, 12]. This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.